Inventor · disambiguated record
Samuel T. Henderson
Also filed as: HENDERSON SAMUEL · HENDERSON SAMUEL T
13 granted patents·23 pending applications·418 citations·filing 2001–2023
92Inventor score
Top patents by PatentIndex Score
36 records- 0197US6835750B1Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism IIACCERA INC·Filed 2002·Granted Dec 28, 2004·178 cites·4 claims
- 0296US8426468B2Use of medium chain triglycerides for the treatment and prevention of alzheimer'S disease and other diseases resulting from reduced neuronal metabolismHENDERSON SAMUEL T·Filed 2012·Granted Apr 23, 2013·56 cites·15 claims
- 0396US8124589B2Use of ketogenic compounds for treatment of age-associated memory impairmentHENDERSON SAMUEL T·Filed 2007·Granted Feb 28, 2012·68 cites·23 claims
- 0495US8748400B2Use of ketogenic compounds for treatment of age-associated memory impairmentHENDERSON SAMUEL T·Filed 2012·Granted Jun 10, 2014·48 cites·22 claims
- 0593US10111849B2Use of medium chain triglycerides for the treatment and prevention of Alzheimer's disease and other diseases resulting from reduced neuronal metabolism IIACCERA INC·Filed 2017·Granted Oct 30, 2018·7 cites·16 claims
- 0687US7280647B2Dynamic photo caller identificationMICROSOFT CORP·Filed 2003·Granted Oct 9, 2007·45 cites·34 claims
- 0786US9125881B2Monoglyceride of acetoacetate and derivatives for the treatment of neurological disordersHENDERSON SAMUEL T·Filed 2009·Granted Sep 8, 2015·4 cites·5 claims
- 0883US9603823B2Use of medium chain triglycerides for the treatment and prevention of Alzheimer's disease and other diseases resulting from reduced neuronal metabolism IIACCERA INC·Filed 2013·Granted Mar 28, 2017·2 cites·6 claims
- 0982US8445535B1Use of medium chain triglycerides for the treatment and prevention of Alzheimer's disease and other diseases resulting from reduced neuronal metabolism IIHENDERSON SAMUEL T·Filed 2004·Granted May 21, 2013·9 cites·7 claims
- 1069US9175345B2Use of genomic testing and ketogenic compounds for treatment of reduced cognitive functionHENDERSON SAMUEL T·Filed 2008·Granted Nov 3, 2015·0 cites·6 claims
- 1167US11559488B2Pharmaceutical compositions having high drug loadings of medium chain triglycerides and methods related theretoCERECIN INC·Filed 2018·Granted Jan 24, 2023·1 cites·25 claims
- 1263US2010034745A1Method for Reducing Levels of Disease Associated ProteinsNEUERA PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 1359US2010041751A1Method to Reduce Oxidative Damage and Improve Mitochondrial EfficiencyACCERA INC·Filed 2009·Application pending·0 cites
- 1457US2008009467A1Combinations of medium chain triglycerides and therapeutic agents for the treatment and prevention of alzheimers disease and other diseases resulting from reduced neuronal metabolismACCERA INC·Filed 2007·Application pending·0 cites
- 1556US2014256808A1Use of Ketogenic Compounds for Treatment of Age-Associated Memory ImpairmentACCERA INC·Filed 2014·Application pending·0 cites
- 1656US2023277459A1Pharmaceutical compositions having high drug loadings of medium chain triglycerides and methods related theretoCERECIN INC·Filed 2023·Application pending·0 cites
- 1754US10105338B2Use of genomic testing and ketogenic compounds for treatment of reduced cognitive functionACCERA INC·Filed 2015·Granted Oct 23, 2018·0 cites·6 claims
- 1854US2006122270A1Use of medium chain triglycerides for the treatment and prevention of Alzheimer's disease and other diseases resulting from reduced neuronal metabolismHENDERSON SAMUEL T·Filed 2006·Application pending·0 cites
- 1953US2006252775A1Methods for reducing levels of disease associated proteinsHENDERSON SAMUEL T·Filed 2005·Application pending·0 cites
- 2053US2013005693A1Method for Reducing Levels of Disease Associated ProteinsACCERA INC·Filed 2012·Application pending·0 cites
- 2153US2025127748A1Methods for the treatment of migraine and related headache symptoms using tricaprylinCERECIN INC·Filed 2022·Application pending·0 cites
- 2252US8105809B2Enzymatic synthesis of acetoacetate esters and derivativesHENDERSON SAMUEL T·Filed 2008·Granted Jan 31, 2012·0 cites·5 claims
- 2352US2007179197A1Compositions and methods for improving or preserving brain functionACCERA INC·Filed 2006·Application pending·0 cites
- 2451US2007135376A1Method to reduce oxidative damage and improve mitochondrial efficiencyACCERA INC·Filed 2006·Application pending·0 cites
- 2551US2024238199A1Stable liquid pharmaceutical compositions having high drug loadings of medium chain triglycerides and methods related theretoCERECIN INC·Filed 2022·Application pending·0 cites
- 2651US2006189545A1Novel chemical entities and methods for their use in treatment of metabolic disordersHENDERSON SAMUEL T·Filed 2004·Application pending·0 cites
- 2749US2024016959A1Radiopharmaceutical ketone and dual tracer imaging in alzheimer's disease, cognitive impairment, and other conditions of altered cerebral metabolismCERECIN INC·Filed 2021·Application pending·0 cites
- 2848US2011003767A1Inhibitors of Acetyl-CoA Carboxylase for Treatment of Neuronal HypometabolismNEUERA PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 2947US2002006959A1Use of medium chain triglycerides for the treatment and prevention of Alzheimer's Disease and other diseases resulting from reduced Neuronal MetabolismFiled 2001·Application pending·0 cites
- 3047US2023372276A1Methods for delivering medium chain triglycerides with controlled pharmacokinetic, safety and tolerability profilesCERECIN INC·Filed 2021·Application pending·0 cites
- 3146US2023181512A1Methods for the treatment of infantile spasms using medium chain triglyceridesCERECIN INC·Filed 2021·Application pending·0 cites
- 3244US2010144875A1Compositions and Methods for Preserving Brain FunctionLARSON BRIAN T·Filed 2006·Application pending·0 cites
- 3343US2010261791A1Compositions and Methods for Improving or Preserving Brain FunctionACCERA INC·Filed 2010·Application pending·0 cites
- 3443US2003059824A1Drug targets for alzheimer's disease and other diseases associated with decreased neuronal metabolismACCERA INC·Filed 2002·Application pending·0 cites
- 3537US2021186915A1Pharmaceutical compositions having high drug loadings of medium chain triglycerides and methods related theretoCERECIN INC·Filed 2019·Application pending·0 cites
- 3632US2022125925A1Medium chain triglyceride formulations with improved bioavailability and methods related theretoCERECIN INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Samuel T. Henderson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →